3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
4
Phase 1/2
3
Phase 1
3
Phase 3
1
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Multiple Myeloma
85
Lymphoma, Follicular
18
Recurrence
11
Lymphoma, Large B-Cell, Diffuse
11
Neoplasms, Plasma Cell
8
Lymphoma
7
Lymphoma, B-Cell, Marginal Zone
6
Lymphoma, Non-Hodgkin
5
Neoplasms
4
Lymphoma, Mantle-Cell
4
Hematologic Diseases
4
Smoldering Multiple Myeloma
3
Leukemia, Lymphocytic, Chronic, B-Cell
3
Disease Progression
3
Paraproteinemias
2
Myelodysplastic Syndromes
2
Disease
2
Anemia
2
Sezary Syndrome
1
Prostatic Neoplasms
1
Polycythemia Vera
1
Plasmacytoma
1
Neoplasm Metastasis
1
Mycosis Fungoides
1
Melanoma
1
Lymphoproliferative Disorders
1
Lymphoma, T-Cell, Cutaneous
1
Limb-girdle muscular dystrophy, type 2C
1
Leukemia, Myelomonocytic, Chronic
1
Leukemia, Myeloid, Acute
1
Interventions
Prednisone
53
Radiotherapy
52
Docetaxel
51
Leuprolide
48
Goserelin
47
bicalutamide
45
enzalutamide
28
acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide
27
Androgen Antagonists
27
Flutamide
24
Triptorelin Pamoate
22
apalutamide
18
Gonadotropin-Releasing Hormone
18
Abiraterone Acetate
17
Radiation
15
abiraterone
14
Zoledronic Acid
14
Magnetic Resonance Spectroscopy
13
gallium 68 PSMA-11
12
Prednisolone
11
luprolide acetate gel depot
10
darolutamide
9
Radiosurgery
9
cabazitaxel
8
Standard of Care
8
Specimen Handling
8
Radiotherapy, Intensity-Modulated
8
Radiotherapy, Conformal
8
Estramustine
8
Dexamethasone
8
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 3
×
Prostatic Neoplasms
×
Lenalidomide
×
Clear all
NCT00988208
2018-04-04
Mainsail
Celgene
Phase 3
Completed
1,059 enrolled
27 charts